HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) has been assigned an average recommendation of “Strong Buy” from the four analysts that are covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a strong buy rating.
Several research analysts recently issued reports on the company. Roth Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Wednesday, December 18th. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Finally, Rosenblatt Securities upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday.
Read Our Latest Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Stock Dividend Cuts Happen Are You Ready?
- Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
- Earnings Per Share Calculator: How to Calculate EPS
- 5 ETFs Poised to Spring Ahead in the Second Quarter
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Stocks With Sky-High Buyback Yields Over the Last 12 Months
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
